7 completed. 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 7 |
Follow this drug Literature Review of PF-04620110 trials Research Report on PF-04620110
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects PF-04620110 or Placebo - Healthy | Phase 1 | Completed | Pfizer | 27 | 2011-06-01 | 2012-01-26 |
| A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients PF-04620110, Placebo - Type 2 Diabetes Patients | Phase 1 | Completed | Pfizer | 48 | 2011-02-01 | 2012-11-06 |
| A Single Dose Study Of PF-04620110 In Healthy Subjects PF-04620110 - Healthy | Phase 1 | Completed | Pfizer | 12 | 2010-07-01 | 2010-08-20 |
| A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects PF-04620110, Placebo - Healthy | Phase 1 | Completed | Pfizer | 60 | 2010-06-01 | 2011-04-19 |
| A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects PF-04620110 - Healthy Volunteers | Phase 1 | Completed | Pfizer | 12 | 2010-02-01 | 2010-03-18 |
| A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers PF-04620110, Placebo - Obesity, Overweight | Phase 1 | Completed | Pfizer | 71 | 2009-08-01 | 2010-06-07 |
| A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers Placebo, PF-04620110 - Overweight | Phase 1 | Completed | Pfizer | 27 | 2008-11-01 | 2009-07-20 |
Overweight (2) · Body Weight (1) · Obesity (1)
Pfizer (7)
Belgium (3) · United States (3) · Singapore (2)